InspireMD. has been granted a patent for a shunting system that regulates blood flow between arterial and venous sides. The system features a separable housing for easy access to a removable blood filter and includes a connector disc facilitating communication between conduits and the filter. GlobalData’s report on InspireMD gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights InspireMD Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on InspireMD, Prosthetic cardiac valves was a key innovation area identified from patents. InspireMD's grant share as of July 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.

Blood flow regulating shunting system with removable filter

Source: United States Patent and Trademark Office (USPTO). Credit: InspireMD Inc

The patent US12070542B2 describes a shunt designed for medical applications, specifically for controlling blood flow in a mammalian patient. The shunt consists of a first housing that accommodates a conduit for blood ingress, along with a regulator that manages the blood flow rate through this conduit. A second housing is removably attached to the first, featuring a cavity that collects blood from the first conduit and is configured to receive a second conduit for blood egress. A blood filter is integrated into the second housing, facilitating communication with the first conduit. Additionally, a connector disc is included, which connects the first conduit and the blood filter, establishing a continuous path for blood flow through the shunt.

The claims further detail the shunt's features, including an adjustable regulator with a trigger lever, a threaded connection for the removable attachment of the housings, and a design that allows for a secure fit of the connector disc within the first housing. The assembly method for the shunt involves attaching the first and second conduits to their respective housings, creating a blood flow pathway between them. The method also outlines the process of regulating blood flow by manipulating the regulator, which can either constrict or allow expansion of the first conduit. This innovative design aims to enhance the efficiency and control of blood transfer in medical settings, particularly in procedures requiring precise blood flow management.

To know more about GlobalData’s detailed insights on InspireMD, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.